← SynDRA
PHA-680632
SynDRA canonical compound SYN0005874 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | AURKA | AURKB | AURKC |
|---|
| Mechanism of action | Aurora kinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Cross-references
Synonyms
- PHA680632
- RefChem:928959
- DTXCID70410854
- C28H35N7O2
- MFCD16038900
- UNII-65W8KZU2A4
- MLS006011048
- orb1300855
- SCHEMBL12582821
- BDBM12110
- GLXC-03443
- HMS3654D10
- EX-A2893
- YQA49379
- BDBM50466806
- EBC-11338
- s1454
- PHA 680632 [WHO-DD]
- AKOS015999833
- CCG-269704
- CS-0194
- SB19305
- SDCCGSBI-0654369.P001
- NCGC00346526-01
- NCGC00346526-04
- AS-56193
- HY-10178
- SMR004702840
- SW219373-1
- T6338
- C75016
- 1,4,5,6-Tetrahydropyrrolo[3,4-c]pyrazole 18
- BRD-K09443272-001-03-3
- N-(2,6-Diethylphenyl)-4,6-dihydro-3-[[4-(4-methyl-1-piperazinyl)benzoyl]amino]pyrrolo[3,4-c]pyrazole-5(1H)-carboxamide
Look up PHA-680632 in the interactive SynDRA portal →